🔗 Share this article

An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Investigational Drug Gaining Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are urged to contact these accounts privately for supplier links, while also obtaining discount codes.

Thriving Trade on Social Networks

Separately, a robust market exists on messaging services, where communities with numerous of members share “before and after” images, administration instructions and assertions of next-day UK delivery. Vendors promote the drug there before redirecting customers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Experts Express Worries

However, physicians and chemists have cautions that the sale of what is still an unapproved drug in the United Kingdom is worrisome and could result in users administering products of uncertain source.

Some experts said the popularity for the experimental drug could be linked to the rising price of licensed slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be marketed or distributed for human use under the British medical regulations.

Some content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate medicines, advertising, and consumer laws, potentially leading to penalties, prosecution or prison.

Platform Reaction and Content Elimination

Based on TikTok, the service has removed violative content and prohibited associated keywords and query recommendations. The organization stated it was dedicated to maintaining the service safe and investing in strengthening enforcement strategies.

Online Marketplace Activities

Investigations also discovered communities with up to nine thousand participants selling retatrutide using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up channels with thousands of members, populated with images of weight loss, glowing testimonials and step-by-step instructions for mixing or injecting at residence.

After moments of joining one group, a seller shared contact information, where the majority of transactions take place. The vendor sent an instruction manual and guaranteed shipping within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about body mass, medical conditions or previous experience.

Item Information and Costs

Inside these communities, posts display dark colored parcels with postal service labels, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors typically sold at £160 for 20mg. When asked how much time a pen should last, sellers give conflicting responses ranging from a several days to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for the messaging service said it regularly monitored dangerous material on its platform including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting materials they cannot confirm. Even if the research behind this drug is valid, these digital versions may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service connected the surge in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit injections are extremely risky. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.

Her team has previously seen individuals harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they said, noting that any product “falsely representing itself as a Lilly investigational substance not yet authorized … may subject patients to possibly serious health risks”.